Receptor- and age-selective effects of dopamine oxidation on receptor-G protein interactions in the striatum

Free Radical Biology and Medicine

Volumn 24, Issue 5, 1998, Pages 827-834

  Joseph, J A ^a   Erat, S ^a   Denisova, N ^a   Villalobos Molina, R ^b  

^a TUFTS UNIVERSITY   (United States)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT(1A) receptors; D1; D2; Dopamine; Free radical; GTPase; Muscarinic; Oxidative stress

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CARBACHOL; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; FREE RADICAL; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; NOMIFENSINE; QUINELORANE; SEROTONIN 1 RECEPTOR;

ADOLESCENT; AGE; AGED; AGING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; ENZYME ACTIVITY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ANTIOXIDANTS; CHROMANS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; FREE RADICALS; GTP-BINDING PROTEINS; MUSCARINIC AGONISTS; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE; SEROTONIN AGONISTS; VITAMIN E;

ANIMALIA;

EID: 0032521121     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00379-1     Document Type: Article

References (66)

1. Dubey A., Forster M. J., Lal H., Sohal R. S. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch. Biochem. Biophys. 333:1996;189-197.
2. Halliwell B. Free radicals and antioxidants A personal view . Nutr. Rev. 52:1994;253-265.
3. Halliwell B., Gutteridge J. M. C. Free radicals in biology and medicine. 1989;Clarendon Press, Oxford, UK.
4. Sohal R. S. The free radical hypothesis of aging An appraisal of the current status . Aging. 5:1993;3-17.
5. Sohal R. S., Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 273:1996;59-63.
6. Yu B. P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 76:1994;139-162.
7. Forster M. J., Dubey A., Dawson K. M., Stutts W. A., Lal H., Sohal R. S. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. USA. 93:1996;4765-4769.
8. +-evoked dopamine release from superfused striatal slices Reversals by PBN or Trolox . Free Radic. Biol. Med. 20:1996;821-830.
9. +-evoked release of endogenous striatal dopamine An indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence . Brain Res. 454:1988;140-148.
10. Joseph J. A., Dalton T. K., Roth G. S., Hunt W. A. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence A deficit at the ligand-muscarinic receptor interface? Brain Res. 454:1988;149-155.
11. Joseph J. A., Kowatch M. A., Maki T., Roth G. S. Selective cross activation/inhibition of second messenger systems and the reduction of age-related deficits in the muscarinic control of dopamine release from perfused rat striata. Brain Res. 537:1990;40-48.
12. 56Fe Implications for long-term space flights . Radiat. Res. 130:1992;88-93.
13. Joseph J. A. The putative role of free radicals in the loss of neuronal functioning in senescence. Integ. Physiol. Behav. Sci. 27:1992;216-227.
14. Choe M., Jackson C., Yu B. P. Lipid peroxidation contributes to age-related membrane rigidity. Free Radic. Biol. Med. 18:1995;977-984.
15. Curtis M. T., Gilfor D., Farber J. L. Lipid peroxidation increases the molecular order of microsomal membranes. Arch. Biochem. Biophys. 235:1984;644-649.
16. Richter C. Biophysical consequences of lipid peroxidation in membranes. Chem. Phys. Lipids. 44:1987;175-179.
17. Viani P., Cervato G., Fioilli A., Cestaro B. Age-related differences in synaptosomal peroxidative damage and membrane properties. J. Neurochem. 56:1991;253-258.
18. Van der Vliet A., Bast A. Effect of oxidative stress on receptors and signal transmission. Chem. Biol. Interact. 85:1992;95-116.
19. M GTPase in striata and hippocampus from aged rat. Brain Res. 576:1992;327-331.
20. M GTPase activity in rat brain. Radiat. Res. 140:1994;382-386.
21. Zhang J. R., Andrus P. K., Hall E. D. Age-related regional changes in hydroxyl radical stress and antioxidants in gerbil brain. J. Neurochem. 61:1993;1640-1647.
22. Carney J. M., Smith C. D., Carney A. M., Butterfield D. A. Aging- and oxygen-induced modifications in brain biochemistry and behavior. Ann. NY Acad. Sci. 738:1994;44-53.
23. Ben-Shachar D., Zuk R., Glinka Y. Dopamine neurotoxicity Inhibition of mitochondrial respiration . J. Neurochem. 64:1995;718-723.
24. Graham D. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14:1978;633-643.
25. Grisham M. B., Perez V. J., Everse J. Neuromelanogenic and cytotoxic properties of canine brainstem peroxidase. J. Neurochem. 48:1987;876-882.
26. Hastings T. G. Enzymatic oxidation of dopamine The role of prostaglandin H synthase . J. Neurochem. 64:1995;919-924.
27. Schipper H. M., Kotake Y., Janzen E. G. Catechol oxidation by peroxidase-positive astrocytes in primary culture An electron spin resonance study . J. Neurosci. 11:1991;2170-2176.
28. Gerlach M., Ben-Shachar D., Riederer P., Youdim M. B. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
29. 3H] dopamine Impact of ascorbic acid and glutathione . J. Neurochem. 63:1994;1126-1132.
30. Fornstedt B., Pileblad E., Carlsson A. In vivo autoxidation of dopamine in guinea pig striatum increases with age. J. Neurochem. 55:1990;655-659.
31. Chiueh C. C., Murphy D. L., Miyake H., Lang K., Tulsi P. K., Huang S. J. Hydroxyl free radical (•OH) formation reflected by salicylate hydroxylation and neuromelanin. In vivo markers for oxidant injury of nigral neurons. Ann. NY Acad. Sci. 679:1993;370-375.
32. Cassel D., Selinger Z. Catecholamine-stimulated GTPase activity in turkey erythrocyte membranes. Biochem. Biophys. Acta. 452:1976;538-551.
33. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;256-275.
34. Folch J., Lees M., Sloane-Stanely G. A simple method for isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
35. Recknagel R. O., Glende E. A. Jr. Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol. 105:1984;331-337.
36. Clemens J. A., Phebus L. A. Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Sci. 42:1988;707-713.
37. Khalil A., Wagner J. R., Lacombe G., Dangoisse V., Fulop T. Increased suseptibility of low-density lipoprotein (LDL) to oxidation by gamma-radiolysis with age. FEBS Lett. 392:1996;45-48.
38. Schmuck A., Fuller C. J., Devaraj S., Jialal I. Effect of aging on susceptibility of low-density lipoproteins to oxidation. Clin. Chem. 41:1995;1628-1632.
39. Lupo G., Anfuso C. D., Alberghina M. Aging does not affect the susceptibility of lipid peroxidation and lysosmal enzyme release of rat visual system structures and sciatic nerve. Neurochem. 23:1993;157-162.
40. Leroux-Nicollet I., Costentin J. Comparison of the subregional distributions of the monoamine vesicular transporter and dopamine uptake complex in the rat striatum and changes during aging. J. Neural Transm. 97:1994;93-106.
41. 3H] dopamine uptake in rat striatum during aging. J. Neurochem. 56:1991;575-579.
42. Modi P. I., Kashyap A., Nair V. D., Ross G. M., Fu M., Savelli J. E., Marcottte E. R., Barlas C., Mishra R. K. Modulation of brain catecholamine absorbing proteins by dopaminergic agents. Eur. J. Pharmacol. 299:1996;213-220.
43. 3H] dopamine from striatal slices. J. Pharmacol. Exp. Ther. 257:1991;262-270.
44. Krebs M. O., Desce J. M., Kemel M. L., Gauchy C., Godeheu G., Cheramy A., Glowinski J. Glutamatergic control of dopamine release in the rat striatum Evidence for presynaptic N-methyl-D-asparate receptors on dopaminergic nerve terminals . J. Neurochem. 56:1991;81-85.
45. De Erausquin G. A., Costa E., Hanbauer I. Calcium homeostasis, free radical formation and trophic factor dependence mechanisms in Parkinson's disease. Pharmacol. Rev. 46:1994;467-482.
46. Forloni G., Lucca E., Angeretti N., Chiesa R., Vezzani A. Neuroprotective effect of somatostatin on non apoptotic NMDA-induced neuronal death Role of cyclic GMP . J. Neurochem. 68:1997;319-327.
47. Hughes P. E., Alexi T., Yoshida T., Schreiber S. S., Knusel B. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. Neuroscience. 74:1996;1143-1160.
48. Patel M., Day B. J., Crapo J. D., Fridovich I., McNamara J. O. Requirement for superoxide in excitotoxic cell death. Neuron. 16:1996;345-355.
49. Schultz J. B., Henshaw D. R., Siwek D., Jenkins B. G., Ferrante R. J., Cipolloni P. B., Kowall N. W., Rosen B. R., Beal M. F. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64:1995;2239-2247.
50. Simpson J. R., Isacson O. Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum. Exp. Neurol. 121:1993;57-64.
51. Brorson J. R., Manzolillo P. A., Gibbons S. J., Miller R. J. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J. Neurosci. 15:1995;4515-4524.
52. Durkin J. P., Tremblay R., Buchan A., Blosser J., Chakravarthy B., Mealing G., Morley P., Song D. An early loss in membrane protein kinase C activity precedes the excitatory amino acid-induced death of primary cortical neurons. J. Neurochem. 66:1996;951-962.
53. Chen Q., Harris C., Brown C. S., Howe A., Surmeier D. J., Reiner A. Glutamate-mediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors. Exp. Neurol. 136:1995;212-224.
54. Gibson G. E., Peterson C. Calcium and aging in the nervous system. Neurobiol. Aging. 8:1987;329-344.
55. Pagliusi S. R., Gerrard P., Abdallah M., Talabot D., Catisicas S. Age-related changes in expression of AMPA-selective glutamate receptor subunits Is calcium-permeability altered in hippocampal neurons? Neuroscience. 61:1994;429-433.
56. Landfield P. W. The role of glucorticoids in brain aging and Alzheimer's disease An integrative physiological hypothesis . Exp. Gerontol. 29:1994;3-11.
57. Landfield P. W., Eldridge J. C. The glucocorticoid hypothesis of age-related hippocampal neurodegeneration Role of dysregulation intraneuronal calcium . Ann. NY Acad. Sci. 746:1994;308-321.
58. Landfield P. W., Thibault O., Mazzanti M. L., Porter N. M., Kerr D. S. Mechanisms of neuronal death in brain aging and Alzheimer's disease Role of endocrine-mediated calcium dyshomeostasis . J. Neurobiol. 23:1992;1247-1260.
59. Martinez-Serrano A., Blanco P., Satrustegui J. Calcium binding to cytosol and calcium extrusion mechanisms in intact synaptosomes and their alterations with aging. J. Biol. Chem. 267:1992;4672-4679.
60. Benzi G., Gorini A., Arnaboldi R., Ghigini B., Villa R. F. Age-related alterations by chronic intermittent hypoxia on cerebral synaptosomal ATPase activities. J. Neural. Transm. Suppl. 44:1994;159-171.
61. 2+-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ. Res. 69:1991;1380-1388.
62. 2+ATPase content is lower in cardicac sarcoplasmic reticulum isolated from old rats. Am. J. Physiol. 264:1993;H1609-H1614.
63. Palumbo A., d'Ischia M., Misuraca G., De Martino L., Prota G. Iron- and peroxide-dependent conjugation of dopamine with cysteine Oxidative routes to the novel brain metabolite 5-S-cysteinyldopamine . Biochem. Biophys. Acta. 1245:1995;255-261.
64. 2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice. Mol. Pharmacol. 49:1996;692-698.
65. Gebicki S., Gebicki J. M. Formation of peroxides in amino acids and proteins exposed to oxygen free radicals. Biochem. J. 289:1993;743-749.
66. Watanabe Y., Sagara Y., Sugahara K., Kodama H. Iminodipeptides containing proline with C-terminal and N-terminal residues prime the stimulation of human neutrophil superoxide generation by fMLP. Biochem. Biophys. Res. Commun. 205:1994;758-764.